S&P 500   2,736.86 (+2.91%)
DOW   23,296.97 (+2.84%)
QQQ   199.84 (+1.75%)
AAPL   265.39 (+2.30%)
FB   173.75 (+2.91%)
MSFT   164.68 (+0.73%)
GOOGL   1,207.80 (+2.13%)
AMZN   2,037.34 (+1.35%)
NVDA   266.34 (+2.82%)
BABA   195.34 (-1.34%)
MU   48.31 (+3.80%)
GE   7.27 (+3.27%)
TSLA   544.62 (-0.15%)
AMD   48.66 (+2.31%)
T   29.78 (-1.00%)
ACB   0.86 (+7.51%)
F   5.00 (+6.16%)
NFLX   369.26 (-0.81%)
BAC   23.27 (+5.06%)
DIS   100.41 (-0.82%)
PRI   97.00 (+10.15%)
S&P 500   2,736.86 (+2.91%)
DOW   23,296.97 (+2.84%)
QQQ   199.84 (+1.75%)
AAPL   265.39 (+2.30%)
FB   173.75 (+2.91%)
MSFT   164.68 (+0.73%)
GOOGL   1,207.80 (+2.13%)
AMZN   2,037.34 (+1.35%)
NVDA   266.34 (+2.82%)
BABA   195.34 (-1.34%)
MU   48.31 (+3.80%)
GE   7.27 (+3.27%)
TSLA   544.62 (-0.15%)
AMD   48.66 (+2.31%)
T   29.78 (-1.00%)
ACB   0.86 (+7.51%)
F   5.00 (+6.16%)
NFLX   369.26 (-0.81%)
BAC   23.27 (+5.06%)
DIS   100.41 (-0.82%)
PRI   97.00 (+10.15%)
S&P 500   2,736.86 (+2.91%)
DOW   23,296.97 (+2.84%)
QQQ   199.84 (+1.75%)
AAPL   265.39 (+2.30%)
FB   173.75 (+2.91%)
MSFT   164.68 (+0.73%)
GOOGL   1,207.80 (+2.13%)
AMZN   2,037.34 (+1.35%)
NVDA   266.34 (+2.82%)
BABA   195.34 (-1.34%)
MU   48.31 (+3.80%)
GE   7.27 (+3.27%)
TSLA   544.62 (-0.15%)
AMD   48.66 (+2.31%)
T   29.78 (-1.00%)
ACB   0.86 (+7.51%)
F   5.00 (+6.16%)
NFLX   369.26 (-0.81%)
BAC   23.27 (+5.06%)
DIS   100.41 (-0.82%)
PRI   97.00 (+10.15%)
S&P 500   2,736.86 (+2.91%)
DOW   23,296.97 (+2.84%)
QQQ   199.84 (+1.75%)
AAPL   265.39 (+2.30%)
FB   173.75 (+2.91%)
MSFT   164.68 (+0.73%)
GOOGL   1,207.80 (+2.13%)
AMZN   2,037.34 (+1.35%)
NVDA   266.34 (+2.82%)
BABA   195.34 (-1.34%)
MU   48.31 (+3.80%)
GE   7.27 (+3.27%)
TSLA   544.62 (-0.15%)
AMD   48.66 (+2.31%)
T   29.78 (-1.00%)
ACB   0.86 (+7.51%)
F   5.00 (+6.16%)
NFLX   369.26 (-0.81%)
BAC   23.27 (+5.06%)
DIS   100.41 (-0.82%)
PRI   97.00 (+10.15%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Adverum BiotechnologiesVericelDBV TECHNOLOGIE/SAerie PharmaceuticalsMesoblast
SymbolNASDAQ:ADVMNASDAQ:VCELNASDAQ:DBVTNASDAQ:AERINASDAQ:MESO
Price Information
Current Price$10.33$10.36$4.22$13.94$5.79
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$18.50$25.00$11.50$39.29$13.83
% Upside from Price Target79.09% upside141.31% upside172.51% upside181.82% upside138.92% upside
Trade Information
Market Cap$713.15 million$425.86 million$429.51 million$590.10 million$600.51 million
Beta2.182.782.350.942.07
Average Volume1,534,159734,406596,441984,790193,793
Sales & Book Value
Annual Revenue$250,000.00$117.85 million$14.75 million$69.89 million$16.72 million
Price / Sales3,292.423.9531.439.2637.20
CashflowN/A$0.24 per shareN/AN/AN/A
Price / CashN/A42.36N/AN/AN/A
Book Value$2.71 per share$2.49 per share$2.11 per share$3.60 per share$4.82 per share
Price / Book3.814.162.003.871.20
Profitability
Net Income$-64,490,000.00$-9,660,000.00$-172,020,000.00$-199,580,000.00$-89,800,000.00
EPS($1.01)$0.18($2.33)($3.40)($0.91)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A26.56N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-8.20%N/A-285.57%-337.18%
Return on Equity (ROE)-36.58%7.84%N/A-85.35%-15.48%
Return on Assets (ROA)-30.02%5.62%N/A-43.24%-11.34%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.16%0.20%0.12%1.20%0.15%
Current Ratio9.06%5.64%3.79%4.50%1.21%
Quick Ratio9.06%5.30%3.75%4.25%1.21%
Ownership Information
Institutional Ownership Percentage75.49%87.34%49.03%N/A2.07%
Insider Ownership Percentage4.20%4.30%15.31%8.71%18.80%
Miscellaneous
Employees8221624435381
Shares Outstanding79.68 million44.95 million109.85 million46.43 million107.43 million
Next Earnings Date5/13/2020 (Estimated)5/5/2020 (Estimated)N/A5/5/2020 (Estimated)6/4/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel